This is a funding opportunity (PAR-25-025) from the NHLBI for early phase clinical trials related to therapeutics and/or diagnostics for Heart, Lung, Blood, and Sleep (HLBS) disorders. It requires an R33 CT (Clinical Trial) application.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Early Phase Clinical Trial for Therapeutics for HLBS Disorders
1
each
$500,000.00
$500,000.00
Medical
Early Phase Clinical Trial for Diagnostics for HLBS Disorders
1
each
$500,000.00
$500,000.00
Medical
Estimated Bid Value
$1,000,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link, plus contracting-officer contacts and AI response outlines. Every feature is free through December 31, 2026.